PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28488786-0	2018	Gadoxetic acid-enhanced magnetic resonance imaging reflects co-activation of beta-catenin and hepatocyte nuclear factor 4alpha in hepatocellular carcinoma.	gadolinium ethoxybenzyl DTPA	0-14	catenin beta 1	Homo sapiens	77-89	
28488786-1	2018	AIM: The aim of this study is to clarify the correlation of the co-activation of beta-catenin and hepatocyte nuclear factor (HNF)4alpha with the findings of gadoxetic acid-enhanced magnetic resonance imaging (MRI), organic anion transporting polypeptide (OATP)1B3 expression, and histological findings in hepatocellular carcinoma (HCC).	gadolinium ethoxybenzyl DTPA	157-171	catenin beta 1	Homo sapiens	81-93	
28488786-6	2018	RESULTS: Enhancement ratio on gadoxetic acid-enhanced MRI in HCC with beta-catenin/GS (+) HNF4alpha (+) was significantly higher than those of the other three groups (P < 0.001).	gadolinium ethoxybenzyl DTPA	30-44	catenin beta 1	Homo sapiens	70-82	
28488786-10	2018	CONCLUSION: Co-activation of beta-catenin and HNF4alpha would promote OATP1B3 expression, and consequently higher enhancement ratio on gadoxetic acid-enhanced MRI and higher differentiation grade in HCC.	gadolinium ethoxybenzyl DTPA	135-149	catenin beta 1	Homo sapiens	29-41